购物车
- 全部删除
- 您的购物车当前为空
Roblitinib (FGF-401) 是一种口服有效的,高选择性的FGFR4抑制剂(IC50:1.9 nM),具有抗癌作用。
Roblitinib (FGF-401) 是一种口服有效的,高选择性的FGFR4抑制剂(IC50:1.9 nM),具有抗癌作用。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 393 | 现货 | |
5 mg | ¥ 828 | 现货 | |
10 mg | ¥ 1,360 | 现货 | |
25 mg | ¥ 2,530 | 现货 | |
50 mg | ¥ 3,980 | 现货 | |
100 mg | ¥ 5,670 | 现货 | |
200 mg | ¥ 7,680 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,350 | 现货 |
产品描述 | Roblitinib (FGF-401) is an inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. Upon administration, Roblitinib binds to and inhibits the activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4-overexpressing cells. Roblitinib is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cell proliferation, differentiation, angiogenesis, and survival. |
靶点活性 | FGFR4:1.1 nM |
体内活性 | FGF-401是一种针对固体肿瘤治疗而开发的FGFR4抑制剂。目前,FGF-401正处于I/II期临床研究中,用于治疗表达FGFR4和KLB阳性的固体肿瘤和肝细胞性癌。 |
别名 | FGF-401 |
分子量 | 506.56 |
分子式 | C25H30N8O4 |
CAS No. | 1708971-55-4 |
Smiles | COCCNc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc23)ncc1C#N |
密度 | 1.39 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Slightly soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容